methylene blue has been researched along with Tauopathies in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (90.91) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Mahajan, S; Mudher, A; Rouiz Ortega, ED; Skoulakis, EMC; Vourkou, E | 1 |
| Csizmadia, G; Keresztes, A; Kiss, R; Mandelkow, E; Pickhardt, M; Solti, K; Tóth, G; Zhu, M | 1 |
| Carlson, GA; Friedman, T; Hyman, BT; Pitstick, R; Polydoro, M; Roe, A; Spires-Jones, TL | 1 |
| Beal, MF; Dumont, M; Elipenahli, C; Gerges, M; Jainuddin, S; Jové, M; Kaidery, NA; Launay, N; Portero-Otin, M; Pujol, A; Stack, C; Starkov, AA; Starkova, N; Tampellini, D; Thomas, B | 1 |
| Close, SP; Davidson, K; Deiana, S; Dietze, S; Goatman, EA; Goatman, K; Harrington, CR; Harrington, KA; Horsley, D; Magbagbeolu, M; Melis, V; Rickard, JE; Riedel, G; Schwab, K; Stamer, K; Storey, JM; Theuring, F; Wischik, CM; Zabke, C | 1 |
| Cadinu, D; Goll, P; Hochgräfe, K; Könen, S; Mandelkow, E; Mandelkow, EM; Matenia, D; Morellini, F; Petrova, O; Pickhardt, M; Sydow, A | 1 |
| Omata, Y; Sheik Mohideen, S; Tsuda, L; Yamasaki, Y; Yoshiike, Y | 1 |
| Binder, L; Bonnefoy, E; Buée, L; Chauderlier, A; Chouala, MS; Delattre, L; Galas, MC; Humez, S; Kayed, R; Lefebvre, B; Marciniak, E; Sultan, A; Tardivel, M; Violet, M | 1 |
| Haass, C; Hruscha, A; Paquet, D; Schmid, B; van Bebber, F | 1 |
| Congdon, EE; Dickey, CA; Duff, KE; Figueroa, YH; Gestwicki, JE; Herman, M; Marinec, PS; Myeku, N; Wu, JW; Yu, WH | 1 |
| Baumeister, R; Biernat, J; Fatouros, C; Koushika, SP; Mandelkow, E; Mandelkow, EM; Pir, GJ; Schmidt, E | 1 |
11 other study(ies) available for methylene blue and Tauopathies
| Article | Year |
|---|---|
Human Tau Aggregates Are Permissive to Protein Synthesis-Dependent Memory in
Topics: Animals; Animals, Genetically Modified; Disease Models, Animal; Drosophila; Humans; Memory Disorders; Methylene Blue; tau Proteins; Tauopathies | 2023 |
Structural Basis of Small Molecule Targetability of Monomeric Tau Protein.
Topics: Humans; Intrinsically Disordered Proteins; Methylene Blue; Molecular Docking Simulation; Molecular Targeted Therapy; Neurofibrillary Tangles; Protein Structure, Tertiary; tau Proteins; Tauopathies | 2018 |
Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy.
Topics: Amyloid beta-Peptides; Animals; Disease Models, Animal; Female; Male; Methylene Blue; Mice; Mice, 129 Strain; Mice, Transgenic; Neurofibrillary Tangles; tau Proteins; Tauopathies | 2014 |
Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity.
Topics: Animals; Behavior, Animal; Cell Line; Female; Gene Expression Regulation; Humans; Methylene Blue; Mice; Mice, Transgenic; Mitochondria; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Sex Factors; Signal Transduction; tau Proteins; Tauopathies | 2014 |
Effects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models.
Topics: Animals; Brain; Cohort Studies; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Learning Disabilities; Maze Learning; Methylene Blue; Mice, Transgenic; Motor Activity; Neurons; Neuroprotective Agents; Oxidation-Reduction; Problem Solving; Random Allocation; Tauopathies | 2015 |
Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau.
Topics: Animals; Behavior, Animal; Cognition; Cognition Disorders; Disease Models, Animal; Enzyme Inhibitors; Humans; Maze Learning; Memory; Methylene Blue; Mice; Mice, Inbred C57BL; Mice, Transgenic; tau Proteins; Tauopathies; Time Factors; Treatment Outcome | 2015 |
Nontoxic singlet oxygen generator as a therapeutic candidate for treating tauopathies.
Topics: Animals; Animals, Genetically Modified; Autophagy; Behavior, Animal; Disease Models, Animal; Drosophila; Female; Humans; Male; Methylene Blue; Oxidative Stress; Singlet Oxygen; Solubility; tau Proteins; Tauopathies | 2015 |
Prefibrillar Tau oligomers alter the nucleic acid protective function of Tau in hippocampal neurons in vivo.
Topics: Animals; Cell Death; Cell Nucleus; Cytoplasm; Disease Models, Animal; DNA Breaks; Female; Fever; Hippocampus; Humans; Methylene Blue; Mice, Transgenic; Neurons; Neuroprotective Agents; Oxidative Stress; Protein Multimerization; RNA; tau Proteins; Tauopathies | 2015 |
Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish.
Topics: Animals; Animals, Genetically Modified; Axons; Blotting, Western; Cell Death; Fluorescent Antibody Technique; Methylene Blue; Neurons; Peptides; Phosphorylation; tau Proteins; Tauopathies; Zebrafish | 2010 |
Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo.
Topics: Animals; Autophagy; Biomarkers; Brain; Cells, Cultured; CHO Cells; Cricetinae; Gene Knockdown Techniques; Humans; Lysosomes; Methylene Blue; Mice; Mice, Transgenic; Microtubule-Associated Proteins; Models, Biological; Neurons; Phosphorylation; Protein Transport; tau Proteins; Tauopathies; Vacuoles | 2012 |
Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity.
Topics: Animals; Animals, Genetically Modified; Axonal Transport; Blood-Brain Barrier; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Disease Models, Animal; Humans; Hydrazines; Methylene Blue; Mitochondria; Motor Neurons; Mutation; Neurons; Neuroprotective Agents; Phenotype; Phosphorylation; Protein Structure, Tertiary; Sensory Receptor Cells; tau Proteins; Tauopathies; Thiazoles; Vesicle-Associated Membrane Protein 1 | 2012 |